Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Renal Nerves in EGP Response to SGLT2 Inhibition
NCT03168295Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Oct 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by UT Health San Antonio. Started Oct 2016; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03168295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03168295.